Early research (Phase 1)Study completedNCT05413551
What this trial is testing
Point-of-care Pharmacogenomic Testing to Optimize Isoniazid Dosing for Tuberculosis Prevention
Who this might be right for
Tuberculosis InfectionIsoniazid Adverse Reaction
Stanford University 73